Xavier Maldonado - Concepedia

Author

Xavier Maldonado

Vall d'Hebron Hospital Universitari ORCID

Also Known As

I. Henríquez, Patricia Willisch, S. Rodriguez, X Maldonado, X. Maldonado, X. Maldonado Pijoan, Xavier Maldonado, Xavier Maldonado Pijoan, Xavier Maldonado-Pijoan, Xavier Maldonado‐Pijoan

139

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Vall d'Hebron Hospital Universitari Hospital Universitario Son Espases Hospital Universitario de La Princesa Hospital General Universitario Gregorio Marañón Institut Català d'Oncologia

About

Xavier Maldonado is an author at Vall d'Hebron Hospital Universitari specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1K
2	Health Sciences	5	5	136
3	Social Sciences	2	2	124
4	Diagnostic Sciences	2	2	71
5	Engineering	1	1	14

Xavier Maldonado

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial A. Zapatero, A. Guerrero, Xavier Maldonado, The Lancet Oncology UrologyRadiation MedicineRadiation TherapyMedicineHigh-dose Radiotherapy	2015	299
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up Joaquim Bellmunt, Anna Orsola, Xavier Maldonado, Annals of Oncology Urological ResearchUrologySurgical OncologyGenitourinary CancerMedicine	2010	166
SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017) Maria Martinez‐García, Juan Álvarez‐Linera, Cristina Carrato, Clinical & Translational Oncology	2017	70
Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus Bicalutamide Malcolm D. Mason, Xavier Maldonado, Christopher P. Steidle, Clinical Oncology UrologyOncologyHigh-risk Prostate CancerGenitourinary CancerDegarelix Versus Goserelin	2012	68
Epileptic features and survival in glioblastomas presenting with seizures Manuel Toledo, Silvana Sarria‐Estrada, Manuel Quintana, Epilepsy Research Neuro-oncologyNeurophysiologyBrain Tumor BiologyNeurologyHigh-grade Gliomas	2016	68
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, The Lancet Factorial DesignUrologyRadiation Medicine× 2Radiation Therapy	2024	65
Prognostic implications of epilepsy in glioblastomas Manuel Toledo, Silvana Sarria‐Estrada, Manuel Quintana, Clinical Neurology and Neurosurgery Neuro-oncologyBrain Tumor BiologyNeurologyHigh-grade GliomasNeuroscience	2015	56
Prostate irradiation in men with de novo, low-volume, metastatic, castration-sensitive prostate cancer (mCSPC): Results of PEACE-1, a phase 3 randomized trial with a 2x2 design. Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, Journal of Clinical Oncology UrologyRadiation MedicinePre-clinical PharmacologyHealth SciencesGenitourinary Cancer	2023	54
High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial A. Zapatero, A. Guerrero, Xavier Maldonado, The Lancet Oncology Radiation MedicineUrologyMedicineBrachytherapyHigh-dose Radiotherapy	2022	41
A phase 3 trial with a 2x2 factorial design of abiraterone acetate plus prednisone and/or local radiotherapy in men with <i>de novo</i> metastatic castration-sensitive prostate cancer (mCSPC): First results of PEACE-1. Karim Fizazi, Xavier Maldonado, Stéphanie Foulon, Journal of Clinical Oncology Rxt QuestionCancer ManagementPharmacotherapyEndocrine OncologyRadiation Medicine	2021	40

Page 1